High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients.

Abstract

These findings indicate that C1qAb measurement is a useful method for detecting the activity of SLE and predicting renal manifestations, but not other organ involvement in the disease.